The Colorectal Cancer Report
Colorectal Cancer (CRC) remains one of the most prevalent cancers globally and a major focus for R&D investment as competition intensifies across treatment settings.
This Report Offers Insight Into:
- Key Targets: Discover the key targets being investigated in CRC drug development, categorized by therapeutic class, so you don’t miss where the next wave of innovation is emerging.
- Biomarkers: Explore the most studied biomarkers by trial phase, to stay aligned with evolving patient selection strategies.
- Leading Clinical Assets: Uncover the drugs leading CRC clinical trial activity, so you can benchmark against the assets gaining the most traction.
- Drug Developers: Identify the top developers driving progress across the CRC pipeline, to understand who you’re really competing with.
You May Also Be Interested In…
Learn More About Oncology
What is Beacon Oncology?
- The Most Comprehensive Way to Search the Oncology Drug Development Landscape: Unique search ontologies based on Oncology drug and trial characteristics
- Market Leading Approach to Oncology Preclinical & Clinical Data Curation: Manual curation of key Oncology research and development data points by Oncology research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Oncology company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
